How oestrogen is actually metabolised
The conventional understanding of oestrogen metabolism stops at the liver: oestrogen is produced in the ovaries, circulates in the blood, is metabolised in the liver, and excreted via bile and urine. That picture is correct — but incomplete.
The step that conventional workup systematically misses is what happens in the gut. The GI Effects® stool panel measures beta-glucuronidase activity as one of its standard markers — precisely because this enzyme is clinically central to oestrogen balance. The Essential Oestrogen test provides the metabolic picture on top of that: how oestrogen is actually broken down in the body and via which pathways.
"Serum oestradiol tells you how much oestrogen you have. It tells you nothing about how it is metabolised, whether it is recirculating via the gut, or whether it is being broken down via a protective or proliferative pathway."
The gut microbiome and the estrobolome
The estrobolome is the collection of gut bacteria genes encoding enzymes capable of metabolising oestrogen. The term was coined by Plottel and Blaser in 2011 and has since been confirmed in multiple clinical studies as a central determinant of systemic oestrogen load.
The mechanism is specific and measurable: the liver conjugates oestrogen with glucuronic acid to enable excretion via bile into the gut lumen. In the gut, these conjugates encounter bacteria that produce beta-glucuronidase — an enzyme that cleaves the glucuronide conjugates and releases oestrogen in its biologically active, free form. The free oestrogen is reabsorbed via enterohepatic recirculation back into the bloodstream.
The consequence is direct: patients with gut dysbiosis and elevated beta-glucuronidase activity recirculate more oestrogen than their primary oestrogen production alone warrants. Systemic oestrogen load is elevated — not due to increased production, but due to decreased elimination.
Beta-glucuronidase — the critical enzyme
Beta-glucuronidase is produced primarily by Bacteroides, Clostridium, Escherichia, and Ruminococcus strains. High activity of these strains — often associated with low-fibre diets, antibiotic exposure, and intestinal inflammation — drives elevated oestrogen recirculation.
Factors that raise beta-glucuronidase activity
- Gut dysbiosis with dominance of beta-glucuronidase-producing strains
- Low-fibre diet — reduces competition from protective bacteria
- High consumption of red and processed meat
- Antibiotic exposure — selectively eliminates protective flora
- Intestinal inflammation — alters gut permeability and microbiome composition
- Alcohol consumption — directly stimulates beta-glucuronidase
Factors that reduce beta-glucuronidase activity
- High fibre intake — prebiotic substrate for protective Lactobacillus and Bifidobacterium
- Calcium D-glucarate — direct competitive inhibitor of beta-glucuronidase
- Probiotics with Lactobacillus strains — outcompete beta-glucuronidase producers
- Cruciferous vegetables (broccoli, cauliflower) — indole-3-carbinol influences hydroxylation pathways
Clinical consequences of elevated beta-glucuronidase
Elevated beta-glucuronidase activity and the enterohepatic oestrogen recirculation it drives has clinical consequences that extend beyond "oestrogen dominance" as an abstract concept:
- Fibroids and endometriosis: oestrogen-dependent proliferative conditions — elevated oestrogen load drives tissue growth independent of primary oestrogen production
- PMS and PMDD: worsened by oestrogen-progesterone imbalance partially driven by gut dysbiosis
- Breast cancer prevention: the 2-OHE1/16α-OHE1 ratio is a validated prognostic marker — gut health directly influences which hydroxylated oestrogen predominates
- Irregular menstruation: without apparent ovarian pathology, the gut microbiome may be a contributing factor
- Hormonally-driven acne: typically investigated from a sebaceous gland perspective, rarely from a gut-oestrogen perspective
The combination of elevated beta-glucuronidase in GI Effects® + aberrant 2-OHE1/16α-OHE1 ratio in Essential Oestrogen is a typical finding in patients with oestrogen dominance and normal serum oestradiol. GI Effects tells you whether the gut is driving recirculation; Essential Oestrogen tells you via which metabolic pathway oestrogen is being broken down. Without both measurements, the intervention is blind — you do not know whether the problem is production, metabolism, or elimination.
The Essential Oestrogen test — the metabolic picture
Essential Oestrogen from Genova Diagnostics is a 24-hour urine-based hormone panel. Urine is the only specimen type that provides a quantitative picture of the oestrogen metabolite composition — serum measures circulating oestrogen at a given moment, but does not capture the breakdown pathways.
The clinically most important marker is the 2-OHE1/16α-OHE1 ratio. 2-hydroxyoestrone is formed via the CYP1A2 enzyme, is biologically weaker, and is associated with lower proliferation risk. 16alpha-hydroxyoestrone is formed via CYP3A4, is biologically potent — it binds the oestrogen receptor with high affinity and stimulates cell growth. A ratio below 2.0 is associated with increased breast cancer risk in several prospective studies.
Interventions aimed at improving the ratio include: indole-3-carbinol (I3C) and diindolylmethane (DIM) from cruciferous vegetables, calcium D-glucarate, treatment of gut dysbiosis, and an anti-inflammatory diet.
If you have symptoms of oestrogen dominance — PMS, bloating, breast tenderness, irregular periods, fibroids — and your serum oestradiol is "normal," the problem may lie in how your oestrogen is metabolised and whether it is being recirculated via the gut.
Gut health and hormonal balance are not separate systems. Beta-glucuronidase is a direct link between them. A complete hormone workup that does not include the gut microbiome and oestrogen metabolism gives an incomplete clinical picture.
Workup protocol — gut and oestrogen together
- GI Effects® Comprehensive: beta-glucuronidase activity, microbiome composition, barrier integrity (zonulin). Provides the picture of whether the gut is driving elevated oestrogen recirculation.
- Essential Oestrogen: complete oestrogen metabolite profile in 24-hour urine. Quantifies the 2-OHE1/16α-OHE1 ratio and identifies whether metabolism is protective or proliferative.
- Menopause Plus: indicated if perimenopausal hormonal reorganisation is part of the clinical picture — provides complementary FSH, LH, and progesterone metabolites.
- NutrEval®: if nutrient deficiency is suspected to affect enzymatic capacity — B12, folate, magnesium, and zinc are cofactors in oestrogen metabolism.